Edwards Lifesciences Corp. (EW) Social Stream
EDWARDS LIFESCIENCES CORP (EW) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EDWARDS LIFESCIENCES CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 19 | $135 | $85 | $119.705 | $81.73 | 46.46% |
| 2021-11-30 | 18 | $135 | $85 | $119.375 | $81.73 | 46.06% |
| 2021-12-06 | 18 | $135 | $85 | $119.375 | $81.73 | 46.06% |
| 2021-12-09 | 19 | $144 | $85 | $122.187 | $81.73 | 49.5% |
| 2021-12-10 | 19 | $144 | $85 | $125.058 | $81.73 | 53.01% |
| 2021-12-15 | 19 | $144 | $85 | $127.705 | $81.73 | 56.25% |
| 2022-01-06 | 19 | $144 | $85 | $129.235 | $81.73 | 58.12% |
| 2022-01-07 | 19 | $148 | $85 | $129.47 | $81.73 | 58.41% |
| 2022-01-24 | 19 | $148 | $85 | $129.294 | $81.73 | 58.2% |
| 2022-01-28 | 19 | $142 | $85 | $126.823 | $81.73 | 55.17% |
| 2022-02-11 | 20 | $142 | $85 | $127.47 | $81.73 | 55.96% |
| 2022-03-08 | 20 | $142 | $85 | $127.611 | $81.73 | 56.14% |
| 2022-03-15 | 21 | $142 | $85 | $127.611 | $81.73 | 56.14% |
| 2022-04-04 | 21 | $142 | $85 | $128 | $81.73 | 56.61% |
| 2022-04-11 | 20 | $142 | $85 | $128.3 | $81.73 | 56.98% |
| 2022-04-13 | 21 | $145 | $85 | $129.095 | $81.73 | 57.95% |
| 2022-04-18 | 20 | $145 | $110 | $132.05 | $81.73 | 61.57% |
| 2022-04-26 | 18 | $145 | $110 | $132.05 | $81.73 | 61.57% |
| 2022-04-27 | 19 | $145 | $110 | $132.05 | $81.73 | 61.57% |
| 2022-04-29 | 19 | $142 | $110 | $132 | $81.73 | 61.51% |
| 2022-05-03 | 19 | $142 | $110 | $131.578 | $81.73 | 60.99% |
| 2022-05-17 | 18 | $142 | $113 | $131.722 | $81.73 | 61.17% |
| 2022-06-13 | 17 | $142 | $105 | $129.882 | $81.73 | 58.92% |
| 2022-07-25 | 17 | $142 | $102 | $125.882 | $81.73 | 54.02% |
| 2022-07-29 | 17 | $142 | $102 | $125.882 | $81.73 | 54.02% |
| 2022-08-01 | 17 | $142 | $106 | $124.47 | $81.73 | 52.29% |
| 2022-09-17 | 17 | $142 | $106 | $123.117 | $81.73 | 50.64% |
| 2022-09-19 | 17 | $142 | $106 | $122.705 | $81.73 | 50.13% |
| 2022-09-23 | 17 | $142 | $106 | $122.411 | $81.73 | 49.77% |
| 2022-10-06 | 17 | $142 | $106 | $121.764 | $81.73 | 48.98% |
| 2022-10-11 | 18 | $142 | $106 | $121.117 | $81.73 | 48.19% |
| 2022-10-12 | 18 | $142 | $106 | $120.5 | $81.73 | 47.44% |
| 2022-10-17 | 18 | $142 | $91 | $119.666 | $81.73 | 46.42% |
| 2022-10-18 | 19 | $142 | $91 | $118.421 | $81.73 | 44.89% |
| 2022-10-25 | 20 | $142 | $91 | $118.421 | $81.73 | 44.89% |
| 2022-10-31 | 20 | $135 | $83 | $105.05 | $81.73 | 28.53% |
| 2022-11-07 | 21 | $135 | $73 | $101.238 | $81.73 | 23.87% |
| 2022-11-30 | 21 | $135 | $73 | $100.619 | $81.73 | 23.11% |
| 2022-12-09 | 21 | $135 | $73 | $97.5 | $81.73 | 19.3% |
| 2022-12-13 | 21 | $135 | $73 | $96.7 | $81.73 | 18.32% |
| 2023-01-03 | 21 | $135 | $73 | $95.35 | $81.73 | 16.66% |
| 2023-01-27 | 20 | $135 | $73 | $96.684 | $81.73 | 18.3% |
| 2023-02-01 | 20 | $135 | $73 | $95.894 | $81.73 | 17.33% |
| 2023-02-02 | 20 | $135 | $75 | $94.444 | $81.73 | 15.56% |
| 2023-03-03 | 19 | $135 | $75 | $95.117 | $81.73 | 16.38% |
| 2023-03-08 | 18 | $134 | $75 | $91.687 | $81.73 | 12.18% |
The Trend in the Analyst Price Target
Over the past 13 months, EW's average price target has gone down $35.78.
Over the past 50 weeks, EW's average upside potential has been 25.74%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-17 | 17 | 142 | 113 | 131.722 | 97.39 | 35.25% |
| 2022-07-29 | 17 | 142 | 102 | 125.882 | 100.54 | 25.21% |
| 2022-09-22 | 17 | 142 | 106 | 122.411 | 84.17 | 45.43% |
| 2022-11-03 | 21 | 135 | 73 | 101.238 | 68.66 | 47.45% |
| 2022-12-14 | 21 | 135 | 73 | 95.350 | 75.82 | 25.76% |
EW Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.92 | 9 | 2 | 8 | 0 | 0 | 19 |
The Trend in the Broker Recommendations
Over the past 14 months, EW's average broker recommendation rating worsened by 0.53.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- EW has a greater number of analysts covering the stock than 5388.06% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, EDWARDS LIFESCIENCES CORP's average analyst price target is greater than 4729.14% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, EDWARDS LIFESCIENCES CORP's upside potential (average analyst target price relative to current price) is higher than 3648.31% of them.
- EW has a lower variance in analysts' estimates than -3047.27% of Medical Equipment stocks.
Stocks similar to EDWARDS LIFESCIENCES CORP in the Medical Equipment industry regarding analyst recommendations and price targets are ALGN, ISRG, and MDT.
View All Top Stocks by Price Target
What is the outlook for EW? Use POWR Ratings for clearer insight into price direction.